Absolute quantification of cell-free microRNAs in cancer patientsManuela Ferracin, Massimo Negrini, Laura Lupini et al.|Oncotarget|2015Cited by 125
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemiaManuela Ferracin, Antonio Cuneo, Barbara Zagatti et al.|Molecular Cancer|2010Cited by 121
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPIGian Matteo Rigolin, Antonio Cuneo, Maurizio Cavallari et al.|Blood|2017Cited by 99
Quantification of Circulating miRNAs by Droplet Digital PCR: Comparison of EvaGreen- and TaqMan-Based ChemistriesElena Miotto, Manuela Ferracin, Laura Lupini et al.|Cancer Epidemiology Biomarkers & Prevention|2014Cited by 99
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristicsGian Matteo Rigolin, Antonio Cuneo, Elena Saccenti et al.|British Journal of Haematology|2018Cited by 45